Inhibiting key metabolic enzyme shows promise against melanoma by Staff September 1, 2022 September 1, 2022 0 views 0Researchers have shown that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. The findings could lead to a new class of drugs to selectively treat melanoma, the most severe form of skin cancer.Source: sciencedaily.com ScienceDaily 0 FacebookTwitterPinterestEmail previous post Review suggests ‘parent-centred’ approach to medical imaging can enhance emotional connection to the unborn baby during pregnancy next post The impact of megafires on estuaries from Australia’s ‘Black Summer’ Related Posts Toxic chemicals from microplastics can be absorbed through... April 19, 2024 Warming of Antarctic deep-sea waters contribute to sea... April 19, 2024 Octopus inspires new suction mechanism for robots April 18, 2024 One third of China’s urban population at risk... April 18, 2024 When thoughts flow in one direction April 18, 2024 Mess is best: Disordered structure of battery-like devices... April 18, 2024